Your browser doesn't support javascript.
loading
Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial.
Dignass, Axel; Schnabel, Robert; Romatowski, Jacek; Pavlenko, Vladimir; Dorofeyev, Andrey; Derova, Jelena; Jonaitis, Laimas; Dilger, Karin; Nacak, Tanju; Greinwald, Roland.
Afiliação
  • Dignass A; Department of Medicine 1, Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany.
  • Schnabel R; Pannónia Magánorvosi Centrum Kft, Budapest, Hungary.
  • Romatowski J; Gastromed sc, Bialystok, Poland.
  • Pavlenko V; State Budgetary Educational Institution of Higher Professional Education, Stavropol, Russian Federation.
  • Dorofeyev A; Regional Bowel Diseases Centre, Donetsk State Medical University, Donetsk, Ukraine.
  • Derova J; Latvian Maritime Medical Centre, Riga, Latvia.
  • Jonaitis L; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Dilger K; Drug Safety, Dr Falk Pharma GmbH, Freiburg, Germany.
  • Nacak T; Clinical Research and Development Department, Dr Falk Pharma GmbH, Freiburg, Germany.
  • Greinwald R; Clinical Research and Development Department, Dr Falk Pharma GmbH, Freiburg, Germany.
United European Gastroenterol J ; 6(1): 138-147, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29435324
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article